Perplexity is raising new investment that would value the search startup at $9 billion, a source familiar with the matter ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...

Baxter, which makes around 60% of the IV solutions used in the US daily, announced that it has restarted its ...

An intravenous (IV) fluid shortage in the wake of Hurricane Helene is continuing after a major North Carolina factory was ...

biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aneurysmal subarachnoid hemorrhage (aSAH) patients ...

The company, which is a key producer for American healthcare providers, was hit by the hurricane when it tore through western ...

The Food and Drug Administration approved changing the expiration date on multiple types of intravenous and sterile fluids made by Baxter International earlier this week, the company said in a ...

The AI-powered search company is set to raise $500 million, according to people familiar with the matter. The venture firm Institutional Venture Partners, which also holds a board seat in the ...

Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading.

according to the company’s website. The Food and Drug Administration declared shortages last Friday of three intravenous drugs produced at Baxter International’s North Carolina plant.

Perplexity is raising new investment that would value the search startup at $9 billion, a source familiar with the matter ...